Alpha 2.0
Login Register
» Articles » PMID: 32931706

Appearance of Pancreatic Sufficiency and Discontinuation of Pancreatic Enzyme Replacement Therapy in Children with Cystic Fibrosis on Ivacaftor

Overview
Journal Ann Am Thorac Soc
Specialty Pulmonary Medicine
Date 2020 Sep 15
PMID 32931706
Citations 5
Authors
Ingrid Hutchinson
Paul McNally
Affiliations
Soon will be listed here.
Citing Articles

Pancreatic enzyme prescription following ivacaftor licensing: A retrospective analysis of the US and UK cystic fibrosis registries.

Calthorpe R, Rosenfeld M, Goss C, Green N, Derleth M, Carr S J Cyst Fibros. 2024; 23(4):746-753.

PMID: 38342635 PMC: 11315808. DOI: 10.1016/j.jcf.2024.01.011.

Going the Extra Mile: Why Clinical Research in Cystic Fibrosis Must Include Children.

Dobra R, Bentley S, Edmondson C, Ovens M, Saunders C, Short C Children (Basel). 2022; 9(7).

PMID: 35884064 PMC: 9323167. DOI: 10.3390/children9071080.

Current clinical opinion on CFTR dysfunction and patient risk of pancreatitis: diagnostic and therapeutic considerations.

Phadke M, Sellers Z Expert Rev Gastroenterol Hepatol. 2022; 16(6):499-509.

PMID: 35623009 PMC: 9256802. DOI: 10.1080/17474124.2022.2084072.

Update in Pediatrics 2020.

Forno E, Abman S, Singh J, Robbins M, Selvadurai H, Schumacker P Am J Respir Crit Care Med. 2021; 204(3):274-284.

PMID: 34126039 PMC: 8513597. DOI: 10.1164/rccm.202103-0605UP.

Challenges in the use of highly effective modulator treatment for cystic fibrosis.

Ramos K, Pilewski J, Taylor-Cousar J J Cyst Fibros. 2021; 20(3):381-387.

PMID: 33531206 PMC: 8192344. DOI: 10.1016/j.jcf.2021.01.007.